Aegerion Pharma Inc (AEGR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2010 | 12-2009 | 12-2008 | |
Cash Flows From Operating Activities | |||
Net Income | -14,254 | -12,196 | -25,035 |
Depreciation Amortization | 10 | 28 | 24 |
Accounts payable and accrued liabilities | 1,730 | -425 | -744 |
Other Working Capital | 1,542 | -813 | -279 |
Other Operating Activity | 2,473 | 2,873 | 4,044 |
Operating Cash Flow | $-8,499 | $-10,532 | $-21,990 |
Cash Flows From Investing Activities | |||
PPE Investments | -12 | N/A | N/A |
Investing Cash Flow | $-12 | $N/A | $N/A |
Cash Flows From Financing Activities | |||
Change In Short Term Borrowing | 7,500 | 5,000 | 16,340 |
Common Stock Issued | 50,801 | N/A | N/A |
Other Financing Activity | -7,118 | -2,044 | -9,737 |
Financing Cash Flow | $51,183 | $2,956 | $6,602 |
Beginning Cash Position | 1,429 | 9,005 | 24,393 |
End Cash Position | 44,101 | 1,429 | 9,005 |
Net Cash Flow | $42,672 | $-7,576 | $-15,388 |
Free Cash Flow | |||
Operating Cash Flow | -8,499 | -10,532 | -21,990 |
Capital Expenditure | -12 | N/A | N/A |
Free Cash Flow | -8,511 | -10,532 | -21,990 |